181 related articles for article (PubMed ID: 25037433)
1. A novel melphalan polymeric prodrug: preparation and property study.
Li D; Lu B; Huang Z; Xu P; Zheng H; Yin Y; Xu H; Liu X; Chen L; Lou Y; Zhang X; Xiong F
Carbohydr Polym; 2014 Oct; 111():928-35. PubMed ID: 25037433
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization, and in vitro efficacy of O-carboxymethyl chitosan conjugate of melphalan.
Lu B; Huang D; Zheng H; Huang Z; Xu P; Xu H; Yin Y; Liu X; Li D; Zhang X
Carbohydr Polym; 2013 Oct; 98(1):36-42. PubMed ID: 23987314
[TBL] [Abstract][Full Text] [Related]
3. Water-soluble porphyrin-PAMAM-conjugates of melphalan and their anticancer activity.
Ramírez-Arroniz JC; Martínez Klimova E; Pedro-Hernández LD; Organista-Mateos U; Cortez-Maya S; Ramírez-Ápan T; Nieto-Camacho A; Calderón-Pardo J; Martínez-García M
Drug Dev Ind Pharm; 2018 Aug; 44(8):1342-1349. PubMed ID: 29521131
[TBL] [Abstract][Full Text] [Related]
4. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of polymeric pH-sensitive STEALTH® nanoparticles for tumor delivery of a lipophilic prodrug of paclitaxel.
Lundberg BB
Int J Pharm; 2011 Apr; 408(1-2):208-12. PubMed ID: 21296135
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro evaluation of a hyaluronic acid-quantum dots-melphalan conjugate.
Xu H; He J; Zhang Y; Fan L; Zhao Y; Xu T; Nie Z; Li X; Huang Z; Lu B; Xu P
Carbohydr Polym; 2015 May; 121():132-9. PubMed ID: 25659681
[TBL] [Abstract][Full Text] [Related]
7. The effect of molecular structure on the anticancer drug release rate from prodrug nanoparticles.
Ikuta Y; Koseki Y; Onodera T; Oikawa H; Kasai H
Chem Commun (Camb); 2015 Aug; 51(64):12835-8. PubMed ID: 26165183
[TBL] [Abstract][Full Text] [Related]
8. Development of enzymatically cleavable prodrugs derived from dendritic polyglycerol.
Calderón M; Graeser R; Kratz F; Haag R
Bioorg Med Chem Lett; 2009 Jul; 19(14):3725-8. PubMed ID: 19553109
[TBL] [Abstract][Full Text] [Related]
9. Folate-polyethylene glycol conjugated carboxymethyl chitosan for tumor-targeted delivery of 5-fluorouracil.
Li HL; He YX; Gao QH; Wu GZ
Mol Med Rep; 2014 Mar; 9(3):786-92. PubMed ID: 24469407
[TBL] [Abstract][Full Text] [Related]
10. Nanoassemblies containing a fluorouracil/zidovudine glyceryl prodrug with phospholipase A2-triggered drug release for cancer treatment.
Jin Y; Yang F; Du L
Colloids Surf B Biointerfaces; 2013 Dec; 112():421-8. PubMed ID: 24036626
[TBL] [Abstract][Full Text] [Related]
11. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
[TBL] [Abstract][Full Text] [Related]
12. A prodrug strategy based on chitosan for efficient intracellular anticancer drug delivery.
Chen C; Zhou JL; Han X; Song F; Wang XL; Wang YZ
Nanotechnology; 2014 Jun; 25(25):255101. PubMed ID: 24896540
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and in vitro release study of a glutathione-dependent polymeric prodrug Cis-3-(9H-purin-6-ylthio)-acrylic acid-graft-carboxymethyl chitosan.
Gong XY; Yin YH; Huang ZJ; Lu B; Xu PH; Zheng H; Xiong FL; Xu HX; Xiong X; Gu XB
Int J Pharm; 2012 Oct; 436(1-2):240-7. PubMed ID: 22750430
[TBL] [Abstract][Full Text] [Related]
14. Comparison in docetaxel-loaded nanoparticles based on three different carboxymethyl chitosans.
Zhang E; Xing R; Liu S; Li K; Qin Y; Yu H; Li P
Int J Biol Macromol; 2017 Aug; 101():1012-1018. PubMed ID: 28389400
[TBL] [Abstract][Full Text] [Related]
15. Development of a photoresponsive chitosan conjugated prodrug nano-carrier for controlled delivery of antitumor drug 5-fluorouracil.
Horo H; Das S; Mandal B; Kundu LM
Int J Biol Macromol; 2019 Jan; 121():1070-1076. PubMed ID: 30342947
[TBL] [Abstract][Full Text] [Related]
16. Development of efficient acid cleavable multifunctional prodrugs derived from dendritic polyglycerol with a poly(ethylene glycol) shell.
Calderón M; Welker P; Licha K; Fichtner I; Graeser R; Haag R; Kratz F
J Control Release; 2011 May; 151(3):295-301. PubMed ID: 21256902
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of chitosan-based long-acting injectable hydrogel for PEGylated melphalan conjugate.
Alexander A; Ajazuddin ; Khan J; Saraf S; Saraf S
J Pharm Pharmacol; 2014 Sep; 66(9):1240-50. PubMed ID: 24824413
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: chitosan-O-isopropyl-5'-O-d4T monophosphate conjugate.
Yang L; Chen L; Zeng R; Li C; Qiao R; Hu L; Li Z
Bioorg Med Chem; 2010 Jan; 18(1):117-23. PubMed ID: 19959368
[TBL] [Abstract][Full Text] [Related]
19. Horseradish peroxidase-encapsulated chitosan nanoparticles for enzyme-prodrug cancer therapy.
Cao X; Chen C; Yu H; Wang P
Biotechnol Lett; 2015 Jan; 37(1):81-8. PubMed ID: 25257586
[TBL] [Abstract][Full Text] [Related]
20. Liposomal Formulation of a Melphalan Lipophilic Prodrug: Studies of Acute Toxicity, Tolerability, and Antitumor Efficacy.
Tretiakova D; Svirshchevskaya E; Onishchenko N; Alekseeva A; Boldyrev I; Kamyshinsky R; Natykan A; Lokhmotov A; Arantseva D; Shobolov D; Vodovozova E
Curr Drug Deliv; 2020; 17(4):312-323. PubMed ID: 32056524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
